日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase I trial of the combination of bortezomib and clofarabine in adults with refractory tumors.

硼替佐米和氯法拉滨联合治疗难治性肿瘤成人患者的 I 期试验。

Ahmed Jibran, DeSouza Andre, Kummar Shivaani, Rubinstein Lawrence, O'Sullivan-Coyne Geraldine, Govindharajulu Jeevan, Herrick William, Ferry-Galow Kate, Li Li, Wilsker Deborah F, Hogu Murielle, Piekarz Richard, Meehan Robert, Salkeni Mohamad Adham, Shin Sarah, Miller Brandon, Zlott Jennifer, Juwara Lamin, Gray Karen, Kuhlmann Laura, Srivastava Apurva, Parchment Ralph E, Doroshow James H, Takebe Naoko, Chen Alice P

A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors

尼洛替尼联合紫杉醇治疗晚期实体瘤患者的I期研究

Shin, Sarah J; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Miller, Sarah B; Johnson, Barry C; Anderson, Larry; Rubinstein, Larry; Miller, Brandon; Wilsker, Deborah F; Ferry-Galow, Katherine V; Piekarz, Richard; Zlott, Jennifer; Hogu, Murielle; Juwara, Lamin; Krushkal, Julia; Konaté, Mariam; Palmisano, Alida; Zhao, Yingdong; Collins, Jerry; Parchment, Ralph E; Doroshow, James H; Chen, Alice P

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

帕博西尼治疗 CDK4 或 CDK6 扩增肿瘤患者的 II 期研究:NCI-MATCH ECOG-ACRIN 试验 (EAY131) 子方案 Z1C 的结果

O'Hara, Mark H; Jegede, Opeyemi; Dickson, Mark A; DeMichele, Angela M; Piekarz, Richard; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Lawrence V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Onitilo, Adedayo; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Cutaneous T-Cell Lymphoma: Yin-Yang Effects of Transcription Factors HLF and NFIL3 in Regulation of Malignant T-Cell Markers in the Context of HDAC Inhibitor Romidepsin Treatment

皮肤T细胞淋巴瘤:转录因子HLF和NFIL3在HDAC抑制剂罗米地辛治疗背景下对恶性T细胞标志物调控的阴阳效应

Kossenkov, Andrew V; Dawany, Noor; Majumdar, Sonali; Chang, Celia; Nichols, Calen; Wysocka, Maria; Piekarz, Richard; Showe, Michael K; Bates, Susan E; Rook, Alain H; Kim, Ellen J; Showe, Louise C

A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndrome

MLN4924 和贝利司他治疗复发/难治性急性髓系白血病或骨髓增生异常综合征的 I 期研究

Maher, Keri R; Shafer, Danielle; Schaar, Dale; Bandyopadhyay, Dipankar; Deng, Xiaoyan; Wright, John; Piekarz, Richard; Rudek, Michelle A; Harvey, R Donald; Grant, Steven

Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas

针对实体瘤和淋巴瘤患者的茚并异喹啉类化合物LMP776和LMP744的I期研究

O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Rubinstein, Larry V; Wilsker, Deborah; Moore, Nancy; Hogu, Murielle; Piekarz, Richard; Covey, Joe; Beumer, Jan H; Ferry-Galow, Katherine V; Villaruz, Liza C; Hollingshead, Melinda G; Holleran, Julianne L; Deppas, Joshua J; Pommier, Yves; Ko, Brian; Johnson, Barry C; Parchhment, Ralph E; Ivy, Percy; Doroshow, James H; Chen, Alice P

A phase 1 study of orally administered 5-fluoro-2'-deoxycytidine with tetrahydrouridine in patients with refractory solid tumors

一项针对难治性实体瘤患者的口服5-氟-2'-脱氧胞苷联合四氢尿苷的I期研究

Chen, Alice P; Kummar, Shivaani; Rubinstein, Larry; Zlott, Jennifer; Coyne, Geraldine O'Sullivan; Chung, Vincent; Newman, Edward M; Lenz, Heinz-Josef; Kelly, Karen; Villaruz, Liza C; Konaté, Mariam M; Ferry-Galow, Katherine V; Wang, Lihua; Kinders, Robert J; Parchment, Ralph E; Covey, Joseph M; Holleran, Julianne L; Piekarz, Richard L; Miller, Sarah B; Juwara, Lamin; Beumer, Jan H; Doroshow, James H

Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial.

恩替诺特、纳武利尤单抗和伊匹木单抗治疗晚期 HER2 阴性乳腺癌女性:一项 Ib 期试验

Roussos Torres Evanthia T, Ho Won J, Danilova Ludmila, Tandurella Joseph A, Leatherman James, Rafie Christine, Wang Chenguang, Brufsky Adam, LoRusso Patricia, Chung Vincent, Yuan Yuan, Downs Melinda, O'Connor Ashley, Shin Sarah M, Hernandez Alexei, Engle Elizabeth L, Piekarz Richard, Streicher Howard, Talebi Zahra, Rudek Michelle A, Zhu Qingfeng, Anders Robert A, Cimino-Mathews Ashley, Fertig Elana J, Jaffee Elizabeth M, Stearns Vered, Connolly Roisin M

A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents

一项多中心 Ib 期临床试验,旨在评估组蛋白去乙酰化酶抑制剂恩替诺特联合帕博利珠单抗治疗对低甲基化药物耐药的骨髓增生异常综合征/肿瘤或急性髓系白血病患者的疗效。

Bewersdorf, Jan Philipp; Shallis, Rory M; Sharon, Elad; Park, Silvia; Ramaswamy, Rahul; Roe, Caroline E; Irish, Jonathan M; Caldwell, Anne; Wei, Wei; Yacoub, Abdulraheem; Madanat, Yazan F; Zeidner, Joshua F; Altman, Jessica K; Odenike, Olatoyosi; Yerrabothala, Swaroopa; Kovacsovics, Tibor; Podoltsev, Nikolai A; Halene, Stephanie; Little, Richard F; Piekarz, Richard; Gore, Steven D; Kim, Tae Kon; Zeidan, Amer M

The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers

肝功能障碍对晚期癌症患者体内贝利司他及其五种代谢物的药代动力学分布的影响

Dunn, Allison; Takebe, Naoko; Chen, Alice; Kummar, Shivaani; Piekarz, Richard; Kiesel, Brian; Moore, Nancy; Doroshow, James; Beumer, Jan H; Gobburu, Jogarao V S